The FDA Patient & Caregiver Connection: Impacting Innovations in Patient Care and Treatment

Melinda Starling
As an extension of AAKP’s National Strategy, AAKP participates in key initiatives that allow us to engage kidney patients in substantive and meaningful efforts designed to impact research over the long-term and help lead to new innovations for medical devices (including diagnostics)
Read More

Innovator Series: Aurinia Pharmaceuticals, Inc.

Melinda Starling
By Robert Huizinga, Ph.D., R.N., CNeph©, Executive Vice President, Corporate Development and Neil Solomons, MD, Chief Medical Officer at Aurinia Pharmaceuticals1. Tell us about your first experience with a kidney patient, personal or professional, and what impressions that left on you as a fellow human being. RH:
Read More

How Are We Going to Open Up Safely?

Melinda Starling
By Stephen Z. Fadem, MD, FASN, Chairman, Medical Advisory Board AAKPIntroduction The COVID-19 pandemic has taken the world by surrise and been costly in terms of life. As of May 27, 2020, there were over 100,000 deaths related to COVID-19 in the United States. By June 8, another 11,700 had died (Source: https://coronavirus.jhu.edu/map.html)
Read More

Medication Management for People with Kidney Disease

Admin
By Tricia Patterson, BSN, RN Hello AAKP members. My name is Tricia Patterson, BSN, RN. I had the pleasure of attending  the AAKP National Patient Meeting in Washington, DC in September and met many of you and heard some great lectures. I am a nephrology nurse and a member of the American Nephrology Nurses Association (ANNA).
Read More